Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Yale Team Identifies Key To Potential New Treatment For Allergy-Induced Asthma
In research that could lead to new asthma drugs, scientists at Yale School of Medicine, Hydra Biosciences of Cambridge, Massachusetts, and the University of California, San Francisco have discovered that a protein may be a trigger of allergy-induced asthma in mice. They also demonstrated how a drug known to reduce inflammatory and neuropathic pain may also inhibit asthma symptoms in mice. Their paper is published in the May 18-22 online Early Edition of the Proceedings of the National Academy of Sciences.
generic viagra online
Merck Statement In Response To The FDA's June 12, 2009 Communication With Updated Information On Leukotriene Inhibitors, Including SINGULAIR(R)
Merck & Co., Inc. issued the following statement in response to today"s communication from the U.S. Food & Drug Administration (FDA) addressing updated information on leukotriene inhibitors, including SINGULAIR® (montelukast sodium).
News of the day
MicroPhage Demonstrates Rapid Diagnostic Platform Feasibility In Skin And Soft Tissue Infections
In a presentation at the current General Meeting of the American Society for Microbiology (ASM) being held in Philadelphia, PA, a simple and inexpensive developmental diagnostic assay produced by MicroPhage, Inc., http://www.microphage.com, was shown to be highly accurate for rapid identification of serious staph bacterial infections from skin and soft tissue infections.
Oncology

Greater Cardiovascular Risk With Small LDL

Small LDL (sLDL) is the most harmful form of cholesterol! People with small LDL are five times as likely to have cardiovascular disease. However, most laboratories do not test for it. Randox provides an easy to use sLDL test to help assess cardiovascular disease risk. Early identification of predominant sLDL can help clinicians manage patients more effectively through more aggressive treatment. The test is available from Randox, and is for use on automated analysers and is no more difficult to use than a standard cholesterol test. This will result in reduction in costs and will save lives. Randox sLDL tests employ direct clearance methodologies removing non-sLDL particles in the initial pre-treatment step. This minimises interference, increasing accuracy and precision. The high performance reagent has an intra-assay precision of less than 5% and shows excellent linearity and sensitivity. Most sLDL assays require laborious testing methods and the ability to run Randox sLDL on automated clinical chemistry analysers reduces time and labour, ultimately reducing laboratory costs. In addition, lipid controls and calibrators are provided with the sLDL kit further reducing costs by consolidation of suppliers. The Randox lipid profile includes total cholesterol, high density lipoprotein (HDL), LDL and apolipoproteins. Testing for sLDL in addition to the above will provide a more comprehensive picture of lipid risk factors and thus enable the clinician to tailor treatment accordingly. Randox Laboratories


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009